Paceart is Changing. Your Data Still Belongs to You.

No. PaceMate states publicly that it is the only company able to migrate comprehensive historical Paceart data. Octagos has migrated complete Paceart repositories for cardiology programs, including discrete clinical fields, full encounter history with PDFs, XML and images, advisory and recall tracking, and billing status with CPT history. Your Paceart database runs in your own environment, and the clinical record in it belongs to your organization. Our engineering team scopes, maps, transfers, and validates the data in house, and your team signs off on integrity before cutover.

Our data stays yours. PaceMate acquired Paceart Optima from Medtronic in 2024, so the platform holding history is now owned by a remote monitoring competitor, and roadmap, support, and pricing decisions sit with that vendor. Where your program goes next is your decision. Octagos migrates the complete repository at no cost, your team validates the data before cutover.

No. If it is in Paceart, we can bring it to Octagos. We routinely migrate 10+ years of history, end to end:

• Patient demographics and locations
• Hardware and leads, including model, serial number, and implant dates
• Full encounter history: PDFs, XML, and images
• Discrete clinical data fields
• Advisory and recall tracking
• Billing status and CPT history

Validation happens record by record, and your team signs off on data integrity before cutover.

Most programs go live in 2 to 12 weeks, averaging about 20 days, with the range driven by data volume and EHR scope. Migration runs in parallel with your EHR integration, which we build in house at no cost. You get a scoped plan with dates before any data moves, and role-based training runs through implementation andafter go-live.

Nothing. Octagos charges no fee for Paceart migration, EHR integration, implementation, training, platform licenses, or the OctaLink mobile app. Our 40+ engineers own the scoping, mapping, transfer, and validation in house, so there is no third-party data conversion invoice either. See pricing for how the platform itself is priced.

Two reasons device clinics give us. First, the platform you stay on is now owned by a remote monitoring competitor, so roadmap, support, and pricing decisions sit with that vendor. Second, Paceart is a data repository, which means your staff still do the reading, the scheduling, the recall tracking, and the billing follow-up.

On Octagos, Atlas AI™ evaluates each transmission against full clinical context and prioritizes by acuity, and in the Two-Brain Approach™ model a US-based, IBHRE-certified device specialist reviews every transmission, with provider oversight on final determinations. Reports follow the same structure every time, so documentation is billing ready.

Both platforms prioritize incoming alerts. What differs is published validation and who reviews each transmission. Octagos pairs Atlas AI triage with review of every transmission by an IBHRE-certified device specialist in the Two-Brain Approach model, and the final report performance is peer reviewed in JACC: Advances: 99.5% accuracy, 99.1% sensitivity, and 99.8% specificity across 690,673 transmissions. As of the date on the comparison above, PaceMateLIVE publishes rules-based alert prioritization and no peer-reviewed accuracy, sensitivity, or specificity figures. Octagos also assigns a dedicated device specialist per account, carries no EHR integration fee, and prices per billable transmission. The row-by-row comparison is in the table above, and there is more on our comparison page and in remote cardiac monitoring companies compared.

No. Octagos runs concurrent operations during cutover, so transmissions keep flowing and your queue stays live while historical data is transferred and validated. Standard service turnaround holds: urgent alerts within one hour and routine transmissions within 24 hours, clinician review included in both windows. Both exceed HRS guidelines.

In-clinic interrogations move to OctaSync™, which ingests in-clinic transmissions including discrete data and PDFs for Medtronic, Boston Scientific, and Biotronik devices. The in-clinic encounter lands in the same queue as remote transmissions, so the same reporting and billing workflow applies to both. Heart failure device data and ambulatory cardiac monitors run through that same workflow, covered on our heart failure and ambulatory monitoring pages.

Yes, and there is no integration fee. Octagos has 200+ live integrations across 20+ EHR systems, including Epic, Oracle Health, athenahealth, eClinicalWorks, and medent, and we build each one in house. Integration is bidirectional over FHIR APIs and HL7, with single sign-on via SMART on FHIR. Inbound clinical context includes medications, problem list, ejection fraction, anticoagulation status, and procedures, up to 240 discrete datapoints. Outbound includes report PDFs, billing drop to encounter, and claims creation in the EHR. More detail is on our IT page.

Octagos prices per billable transmission, so the platform earns when your program bills. There are no volume-based fees that climb as your panel grows, and no EHR integration fees. Health systems can mix service models by site, from software only up to full service with IBHRE-certified device specialist review, and the same model applies at 50 patients or 50,000. Customers routinely report two- to three-fold increases in clinic revenue, a customer-reported result and not a guarantee. We will build a pro-forma onyour actual device population.

Yes. Octagos maintains ISO 27001, SOC 2 Type II, SOC 3, and HITRUST certification, and operates in compliance with HIPAA. Controls include annual penetration testing, role-based access, multi-factor authentication, end-to-end encryption, a full audit trail for every alert and action, and a real-time security and compliance dashboard. Documentation is available for your IT and compliance review before cutover.